{"disease":{"id":"recurrent-metastatic-squamous-cell-carcinoma-of-the-head-and-neck-hnscc","name":"recurrent metastatic squamous cell carcinoma of the head and neck hnscc"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04815720","title":"Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Vaccinex Inc.","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}